Value
3.8/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 6.1 |
| EV/EBITDA | 2.0 |
| p ocf | 6.8 |
| Analyst target | 3.0 |
- ▸P/OCF: 15.6x (FFO proxy — REITs gated off P/E)
HR · Why this verdict
Why Healthcare Realty Trust Incorpo (HR) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.0/10
ConfidenceHIGH
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The stock has moved above its near-term resistance ceiling, leaving essentially no remaining headroom — and producing a negative risk/reward — where downside materially exceeds any residual upside at current prices. Price targets | For the setup to become favorable, analyst-consensus price targets would need to be revised upward above $24, restoring at least 15% headroom from the current $20.51 level. | →Stable |
| CounterTechnical resistance levels are temporary; a positive earnings catalyst or sector re-rating could push targets higher and quickly restore a favorable entry geometry without waiting for a meaningful pullback. | ||
The business scores below the minimum quality threshold, with no identifiable competitive moat and GAAP losses despite modest free-cash-flow generation at a 12% margin, indicating the franchise lacks the durability characteristics typically required to support a long position through a full cycle. Quality breakdown | Free cash flow margin expands from the current 12% to above 18% over the next two fiscal years while GAAP profitability turns consistently positive, demonstrating broad-based improvement in business quality. | →Stable |
| CounterHealthcare real estate trusts can generate stable cash flows from long-term leases even without a traditional competitive moat; the GAAP loss may primarily reflect depreciation treatment rather than operational weakness, and free cash flow is already positive. | ||
A put/call ratio of 3.25 indicates that options market participants are positioned heavily toward downside protection, suggesting institutional hedging or directional short bets that add a persistent near-term headwind to price appreciation. Risk breakdown | Put/call ratio normalizes below 1.5 as holders unwind hedges and bearish positioning reverses, signaling a shift in institutional sentiment. | →Stable |
| CounterElevated put/call ratios can occasionally serve as a contrarian buy signal when fear peaks; if the position is already well-hedged institutionally, the stock may absorb negative news more smoothly than the ratio implies. | ||
The dividend yield is flagged as unsustainably high relative to the business's cash-generation capacity, raising the risk that the distribution may be cut — which would impair both income return and the stock's core holder base simultaneously. Catalyst breakdown | The company demonstrates dividend coverage by reporting two consecutive quarters in which free cash flow fully covers the distribution with at least 20% cushion above the payout, confirming the yield is organically funded. | →Stable |
| CounterREITs typically fund distributions from funds from operations rather than GAAP free cash flow; if FFO per share is sufficient to cover the payout, the headline sustainability concern may overstate the actual cut risk. | ||
The stock has moved above its near-term resistance ceiling, leaving essentially no remaining headroom — and producing a negative risk/reward — where downside materially exceeds any residual upside at current prices.
→StablePrice targets
- Expectation
- For the setup to become favorable, analyst-consensus price targets would need to be revised upward above $24, restoring at least 15% headroom from the current $20.51 level.
CounterTechnical resistance levels are temporary; a positive earnings catalyst or sector re-rating could push targets higher and quickly restore a favorable entry geometry without waiting for a meaningful pullback.
The business scores below the minimum quality threshold, with no identifiable competitive moat and GAAP losses despite modest free-cash-flow generation at a 12% margin, indicating the franchise lacks the durability characteristics typically required to support a long position through a full cycle.
→StableQuality breakdown
- Expectation
- Free cash flow margin expands from the current 12% to above 18% over the next two fiscal years while GAAP profitability turns consistently positive, demonstrating broad-based improvement in business quality.
CounterHealthcare real estate trusts can generate stable cash flows from long-term leases even without a traditional competitive moat; the GAAP loss may primarily reflect depreciation treatment rather than operational weakness, and free cash flow is already positive.
A put/call ratio of 3.25 indicates that options market participants are positioned heavily toward downside protection, suggesting institutional hedging or directional short bets that add a persistent near-term headwind to price appreciation.
→StableRisk breakdown
- Expectation
- Put/call ratio normalizes below 1.5 as holders unwind hedges and bearish positioning reverses, signaling a shift in institutional sentiment.
CounterElevated put/call ratios can occasionally serve as a contrarian buy signal when fear peaks; if the position is already well-hedged institutionally, the stock may absorb negative news more smoothly than the ratio implies.
The dividend yield is flagged as unsustainably high relative to the business's cash-generation capacity, raising the risk that the distribution may be cut — which would impair both income return and the stock's core holder base simultaneously.
→StableCatalyst breakdown
- Expectation
- The company demonstrates dividend coverage by reporting two consecutive quarters in which free cash flow fully covers the distribution with at least 20% cushion above the payout, confirming the yield is organically funded.
CounterREITs typically fund distributions from funds from operations rather than GAAP free cash flow; if FFO per share is sufficient to cover the payout, the headline sustainability concern may overstate the actual cut risk.
TrendMatrix Research · core thesis
Engine thesis — one sentence
A healthcare real estate trust trading above its near-term technical resistance with a quality profile below the minimum investment threshold — no competitive moat, declining revenue, an elevated put/call ratio of 3.25 signaling heavy institutional hedging, and a flagged dividend sustainability concern — presents an unfavorable risk/reward that argues for exiting or avoiding the position.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
3.2/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.5 |
| Gross margin | 8.4 |
| Op margin | 4.6 |
| Net margin | 0.0 |
| Current ratio | 1.2 |
| FCF quality | 5.5 |
| Moat | 4.0 |
| Piotroski F | 4.4 |
- ▸FCF-positive despite GAAP loss (FCF margin 12%, FCF yield 2.0%)
- ▸No competitive moat
Growth
0.9/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 0.9 |
- ▸Declining revenue: -6%
Momentum
5.7/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 3.8 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 0.0 |
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
5.1/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 5.4 |
| erm sentiment | 5.0 |
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
- ▸Insider selling (low materiality) — $524,874 (0.007% of mkt cap)
Peer rank
3.0/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 5.0 |
| quality rank | 1.3 |
| growth rank | 0.6 |
Technical
5.0/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 3.1 |
| support resistance | 2.2 |
| 52w position | 9.7 |
Risk (lower is worse)
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.4 |
| days to cover | 6.4 |
| volatility | 7.8 |
| put call | 10.0 |
| implied vol | 3.8 |
| beta | 8.1 |
| debt equity | 5.2 |
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| dividend safety | 3.5 |
- ▸Yield trap warning: high yield but unsafe
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (7)
- MOMENTUM:5.7>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:24d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-1.9=NEGATIVE
Warning (0)
none
Reward-to-Risk
-1.85
Upside
-10.8%
Downside
5.8%
Sizing output
AVOID
SetupRange Bound — RSI 51 mid-range, Bollinger mid-band
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Risk (lower is worse) at 6.7 could not lift the engine output above the verdict floor. Failed gate signal: ASYMMETRY:-1.9=NEGATIVE.
The strongest dimensions are Risk (lower is worse) at 6.7, Catalyst at 6.7, and Momentum at 5.7; the weakest are Growth at 0.9, Peer rank at 3.0, and Quality at 3.2. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of -1.85 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Price Above Target Negative Geometry
Trip ifAnalyst consensus price target revises above $24.00 (more than 15% above the current $20.51), restoring positive asymmetry.
- P2Quality Below Minimum Floor
Trip ifFree cash flow margin expands above 18% AND GAAP net income turns positive for 2 consecutive quarters.
- P3Elevated Put Call Institutional Hedging
Trip ifPut/call ratio falls below 1.0 for 3 consecutive weeks.
- P4Dividend Yield Sustainability Concern
Trip ifDividend per share is maintained at or above current levels for 4 consecutive quarters while free cash flow coverage of the distribution exceeds 1.2x.